Table 3.
Effect of pterocarpan-high soy leaf extract supplementation on changes of BMI, BFP, WHR-related body measurements and blood pressure in subjects with metabolic syndrome.
| Placebo | PT | Time × Group, p Value † | |||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| Body weight (kg) | 67.79 ± 1.50 | 67.25 ± 1.56 | 66.09 ± 2.08 | 64.80 ± 2.23 | 0.174 |
| BMI (kg/m2) | 25.97 ± 0.39 | 25.65 ± 0.38 | 25.51 ± 0.40 | 25.15 ± 0.44 | 0.827 |
| BFP (%) | 32.08 ± 0.95 | 31.14 ± 0.87 | 32.41 ± 0.72 | 31.04 ± 0.77 | 0.122 |
| WHR | 0.87 ± 0.01 | 0.88 ± 0.01 | 0.85 ± 0.01 | 0.85 ± 0.01 | 0.174 |
| Systolic BP (mmHg) | 136.45 ± 2.77 | 128.77 ± 2.38 | 131.68 ± 3.12 | 126.00 ± 3.37 * | 0.624 |
| Diastolic BP (mmHg) | 81.24 ± 1.83 | 77.12 ± 2.05 | 76.54 ± 2.73 | 72.13 ± 2.62 | 0.497 |
Values are the mean ± SE. Placebo, starch; PT, pterocarpan-high soy leaf extract (2 g/day); BMI, body mass index; BFP, body fat percentage; VFA, visceral fat area; WHR, waist-hip ratio; BP, blood pressure. * p < 0.05 paired t-test between before and after trial in each group; † p < 0.05 general linear model for repeated measures ANOVA.